Transaction DateRecipientSharesTypePriceValue
25th November 2020John Hadden500Open or private purchase$5.48$2,737.85
2nd September 2020Rita M O'Connor2,120Open or private purchase$3.83$8,126.60
1st September 2020Rita M O'Connor4,500Open or private purchase$3.74$16,837.20
21st August 2020Rita M O'Connor4,050Open or private purchase$3.97$16,090.65
20th August 2020Rita M O'Connor2,300Open or private purchase$3.77$8,665.71
20th May 2019Michael J Valentino44,404Open or private purchase$5.60$248,662.40
P Lx Pharma
P Lx Pharma logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 4/10.

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company. Its products include Vazalore 325 mg and PL1200 Ibuprofen 200 mg.

Ticker: PLXP
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
SEC Central Index Key (CIK): 1497504
Employees: 15
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags